Cholesterol and mortality. 30 years of follow-up from the Framingham study
- PMID: 3560398
- DOI: 10.1001/jama.257.16.2176
Cholesterol and mortality. 30 years of follow-up from the Framingham study
Abstract
From 1951 to 1955 serum cholesterol levels were measured in 1959 men and 2415 women aged between 31 and 65 years who were free of cardiovascular disease (CVD) and cancer. Under age 50 years, cholesterol levels are directly related with 30-year overall and CVD mortality; overall death increases 5% and CVD death 9% for each 10 mg/dL. After age 50 years there is no increased overall mortality with either high or low serum cholesterol levels. There is a direct association between falling cholesterol levels over the first 14 years and mortality over the following 18 years (11% overall and 14% CVD death rate increase per 1 mg/dL per year drop in cholesterol levels). Under age 50 years these data suggest that having a very low cholesterol level improves longevity. After age 50 years the association of mortality with cholesterol values is confounded by people whose cholesterol levels are falling--perhaps due to diseases predisposing to death.
Similar articles
-
Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.Kardiol Pol. 2016;74(3):262-73. doi: 10.5603/KP.a2015.0175. Epub 2015 Sep 14. Kardiol Pol. 2016. PMID: 26365939
-
The Association Between Low Serum Cholesterol and Non-Cardiovascular Mortality among Italian Males and Females: A Nine- Year Prospective Cohort Ctudy.Asian Pac J Cancer Prev. 2019 May 25;20(5):1361-1368. doi: 10.31557/APJCP.2019.20.5.1361. Asian Pac J Cancer Prev. 2019. PMID: 31127892 Free PMC article.
-
Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United States collaborative study on cardiovascular epidemiology).Am J Cardiol. 1999 Sep 1;84(5):540-8. doi: 10.1016/s0002-9149(99)00374-4. Am J Cardiol. 1999. PMID: 10482152
-
Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up.Am J Cardiol. 2017 Apr 15;119(8):1193-1198. doi: 10.1016/j.amjcard.2017.01.008. Epub 2017 Jan 25. Am J Cardiol. 2017. PMID: 28267961
-
Lipid metabolism and cardiovascular risk: should hypercholesterolemia be treated in the elderly?J Hypertens Suppl. 1992 Apr;10(2):S65-8. J Hypertens Suppl. 1992. PMID: 1593305 Review.
Cited by
-
Mechanism of Hypercholesterolemia-Induced Atherosclerosis.Rev Cardiovasc Med. 2022 Jun 9;23(6):212. doi: 10.31083/j.rcm2306212. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077184 Free PMC article. Review.
-
Association and its population heterogeneities between low-density lipoprotein cholesterol and all-cause and cardiovascular mortality: A population-based cohort study.Chin Med J (Engl). 2024 Sep 5;137(17):2075-2083. doi: 10.1097/CM9.0000000000003199. Epub 2024 Jul 30. Chin Med J (Engl). 2024. PMID: 39075633 Free PMC article.
-
Introducing Attribute Association Graphs to Facilitate Medical Data Exploration: Development and Evaluation Using Epidemiological Study Data.JMIR Med Inform. 2024 Jul 24;12:e49865. doi: 10.2196/49865. JMIR Med Inform. 2024. PMID: 39046780 Free PMC article.
-
Explaining adverse cholesterol levels and distinct gender patterns in an Indonesian population compared with the U.S.Econ Hum Biol. 2024 Aug;54:101403. doi: 10.1016/j.ehb.2024.101403. Epub 2024 May 25. Econ Hum Biol. 2024. PMID: 38861883 Free PMC article.
-
Effect of Exercise Training on Lipoprotein Subclass Particle Concentrations and Sizes in Older Women: Results from a Randomized Controlled Trial.Geriatrics (Basel). 2023 Nov 29;8(6):116. doi: 10.3390/geriatrics8060116. Geriatrics (Basel). 2023. PMID: 38132487 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
